Treatment free remission after combination therapy with asciminib (ABL001) plus imatinib in chronic phase chronic myeloid leukemia (CP-CML) patients who relapsed after a prior attempt at TKI discontinuation-H Jean Khoury Cure CML Consortium study Meeting Abstract
| Authors: | Mauro, M.; Visotcky, A.; Flynn, K. E.; Radich, J. P.; Yang, J.; Oehler, V. G.; Cortes, J. E.; Kota, V. K.; Tantravahi, S. K.; Baim, A.; Zhang, M. J.; Hinman, A.; Atallah, E. L.; Sweet, K. |
| Abstract Title: | Treatment free remission after combination therapy with asciminib (ABL001) plus imatinib in chronic phase chronic myeloid leukemia (CP-CML) patients who relapsed after a prior attempt at TKI discontinuation-H Jean Khoury Cure CML Consortium study |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 6765 |
| End Page: | 6766 |
| Language: | English |
| ACCESSION: | WOS:000893223206347 |
| DOI: | 10.1182/blood-2022-160138 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
